title: Comment on: induction treatment of ANCA-associated vasculitis with a single dose of rituximab: reply.
authors.affiliation: UCL Centre for Nephrology, Royal Free Hospital, London, UK and Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
authors.forename: Tabitha
authors.initials: T
authors.lastname: Turner-Stokes
authors.affiliation: UCL Centre for Nephrology, Royal Free Hospital, London, UK and Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
authors.forename: Eleanor
authors.initials: E
authors.lastname: Sandhu
authors.affiliation: UCL Centre for Nephrology, Royal Free Hospital, London, UK and Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
authors.forename: Ruth J
authors.initials: RJ
authors.lastname: Pepper
authors.affiliation: UCL Centre for Nephrology, Royal Free Hospital, London, UK and Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
authors.forename: Alan D
authors.initials: AD
authors.lastname: Salama
authors.affiliation: UCL Centre for Nephrology, Royal Free Hospital, London, UK and Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland.
authors.forename: Aine
authors.initials: A
authors.lastname: Burns
authors.affiliation: UCL Centre for Nephrology, Royal Free Hospital, London, UK and Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland mlittle@tcd.ie.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Little
mesh_terms: D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000188:drug therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors